Comparing scans to find parathyroid gland disease
Part of Hormones & metabolism clinical trials.
This study compares a newer type of scan (18F-choline PET/CT) to standard imaging to help doctors locate overactive parathyroid glands. The goal is to see if the newer scan works better for planning surgery in people with primary hyperparathyroidism.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a condition called primary hyperparathyroidism, meaning your parathyroid glands are making too much hormone.
- You and your doctor have decided that surgery is the right next step.
- You are 18 years of age or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special PET scan to better locate overactive parathyroid glands before surgery. It may help guide treatment for people with primary hyperparathyroidism.
This study tests two advanced imaging techniques (PET/MR and PET/CT) to find overactive parathyroid glands or tumors that need surgery. Participants get a special scan before surgery to help surgeons locate the problem more accurately.
This trial tests whether a special scan (Choline PET/CT) can replace a blood test done during surgery (PTH) to guide treatment for primary hyperparathyroidism, making surgery simpler.
This study looks at whether taking calcitonin before a special parathyroid scan (SPECT-CT) makes the scan easier to read. It’s for people with primary hyperparathyroidism who want surgery, and may help doctors find the right gland more reliably.
This trial tests whether a special camera (autofluorescence) can help surgeons find abnormal parathyroid glands during surgery for primary hyperparathyroidism. It involves exploratory surgery, not a focused approach, and may help improve surgical success.
This study compares a Sestamibi scan (with a special camera) versus a Fluorocholine scan (with PET/CT) to see which one better finds a suspected parathyroid adenoma. If your tests suggest a parathyroid problem but the first Sestamibi scan is negative or unclear, this trial may help answer the next best scan choice.
Hear when a new Primary Hyperparathyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.